ExploreWatchlistsPricing
  1. JP-listed companies
  2. JCR Pharmaceuticals Co.,Ltd.
  3. Financials
  4. Gross profit

JCR Pharmaceuticals Co.,Ltd. (4552)

Market cap
¥73.8B
P/E ratio
43.4x
JCR Pharma develops and manufactures pharmaceutical and regenerative medicine products for healthcare providers worldwide, with specialized focus on advanced regenerative treatments.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndGross profit (Million JPY)YoY (%)
Mar 31, 202521,738-30.44%
Mar 31, 202431,251+22.76%
Mar 31, 202325,456-37.33%
Mar 31, 202240,620+82.38%
Mar 31, 202122,272+31.94%
Mar 31, 202016,880+1.74%
Mar 31, 201916,592+14.70%
Mar 31, 201814,465+17.09%
Mar 31, 201712,353+12.52%
Mar 31, 201610,979-1.22%
Mar 31, 201511,115

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat